Table 4 Effect of PTEN status on tumor-associated immune cell infiltrates

From: Identification of a subset of microsatellite-stable endometrial carcinoma with high PD-L1 and CD8+ lymphocytes

Variable

Tumor PTEN negative (59/132; 45%)

Tumor PTEN positive/heterogeneous (73/132; 55%)

p-Value

CD3 (mean cells/mm2, SD)

  Overall

879 (556)

899 (575)

0.967

  Hotspot

1466 (777)

1454 (868)

0.714

  Periphery

908 (575)

900 (678)

0.517

  Center

846 (588)

879 (562)

0.643

CD8 (mean cells/mm2, SD)

  Overall

462 (411)

495 (464)

0.969

  Hotspot

781 (596)

803 (631)

0.998

  Periphery

507 (472)

526 (500)

0.844

  Center

413 (404)

464 (481)

0.912

CD68 (mean cells/mm2, SD)

  Overall

194 (159)

163 (119)

0.332

  Hotspot

324 (232)

274 (196)

0.175

  Periphery

182 (144)

156 (130)

0.219

  Center

204 (182)

175 (137)

0.560